APT Pharmaceuticals is a drug-development company focused on treatments for significant unmet medical needs.
APT Pharmaceuticals is a drug development company focused on repurposing well-characterized drugs for under-served populations.APT’s initial focus is on the pulmonary delivery of treatments for serious lung diseases.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 30, 2008 | Series B | $32M | 1 | — | — | Detail |
Oct 5, 2007 | Series A | $22M | 1 | Versant Ventures | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Versant Ventures | — | Series B |